Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial Meeting Abstract

  


Authors: Reichardt, P.; Demetri, G.; Kang, Y. K.; Blay, J. Y.; Joensuu, H.; Maki, R.; Rutkowski, P.; Hohenberger, P.; Gelderblom, H.; Leahy, M.; von Mehren, M.; Schöffski, P.; Blackstein, M.; Le Cesne, A.; Badalamenti, G.; Xu, J.; Nishida, T.; Laurent, D.; Kuss, I.; Casali, P.
Abstract Title: Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie
Journal Title: Onkologie
Volume: 35
Issue: Suppl.6
Meeting Dates: 2012 Oct 19-23
Meeting Location: Stuttgart, Germany
ISSN: 0378-584X
Publisher: S. Karger AG  
Date Published: 2012-10-01
Start Page: 168
Language: English
ACCESSION: WOS:000310766700436
PROVIDER: wos
Notes: Meeting Abstract: V563 -- English Translation of Meeting Title: 2012 Meeting of the German, Austrian and Swiss Societies of Hematology and Oncology -- "Source: Wos"